Financial data analysis helps to confirm if markets are presently mispricing Resmed Inc DRC. We were able to break down twenty-nine available financial ratios for Resmed Inc DRC, which can be compared to its competitors. The stock experiences a normal downward trend and little activity. Check odds of Resmed to be traded at 38.02 in 90 days. Key indicators impacting Resmed's financial strength include:
Understanding current and past Resmed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Resmed's financial statements are interrelated, with each one affecting the others. For example, an increase in Resmed's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Resmed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Resmed Inc DRC. Check Resmed's Beneish M Score to see the likelihood of Resmed's management manipulating its earnings.
Resmed Stock Summary
Resmed competes with WA1 Resources, and Zip Co. Resmed is entity of Australia. It is traded as Stock on AU exchange.
You should never invest in Resmed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Resmed Stock, because this is throwing your money away. Analyzing the key information contained in Resmed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Resmed Key Financial Ratios
Resmed's financial ratios allow both analysts and investors to convert raw data from Resmed's financial statements into concise, actionable information that can be used to evaluate the performance of Resmed over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Resmed competition to find correlations between indicators driving Resmed's intrinsic value. More Info.
Resmed Inc DRC is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Resmed Inc DRC is roughly 1.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.
Resmed Inc DRC Systematic Risk
Resmed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Resmed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Resmed Inc DRC correlated with the market. If Beta is less than 0 Resmed generally moves in the opposite direction as compared to the market. If Resmed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Resmed Inc DRC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Resmed is generally in the same direction as the market. If Beta > 1 Resmed moves generally in the same direction as, but more than the movement of the benchmark.
Resmed Inc DRC Total Assets Over Time
Resmed December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Resmed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Resmed Inc DRC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Resmed Inc DRC based on widely used predictive technical indicators. In general, we focus on analyzing Resmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Resmed's daily price indicators and compare them against related drivers.
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.